Making the hypothesis that reversing HLA-DR down-regulation on alveolar monocytes would improve outcomes, Herold et al. administrated inhaled GM-CSF in six patients with pneumonia-related ARDS with documented decreased HLA-DR expression on alveolar monocytes, as a compassionate intervention [42]. Here, CSF2 is linked to acute respiratory distress syndrome.